# Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti

> **NCT00876434** · PHASE1 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 5 (actual)

## Conditions studied

- Anterior Uveitis

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00876434
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-01
- **Primary completion:** 2011-02-10
- **Final completion:** 2011-02-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876434, "Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00876434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*